» Articles » PMID: 15753432

Alzheimer Disease and Cancer

Overview
Journal Neurology
Specialty Neurology
Date 2005 Mar 9
PMID 15753432
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Cross-sectional studies raise the possibility of protective relationships between, or a common mechanism underlying, the development of dementia of the Alzheimer type (DAT) and cancer. Using a prospective longitudinal design, the authors found that the risk of developing cancer is less among participants with DAT vs nondemented participants (p < 0.001) and that the risk of developing DAT may be less for participants with a history of cancer (p = 0.060).

Citing Articles

Lower Incidence of Dementia Following Cancer Diagnoses: Evidence from a Large Cohort and Mendelian Randomization Study.

Bassil D, Zheng B, Su B, Kafetsouli D, Udeh-Momoh C, Tzoulaki I J Prev Alzheimers Dis. 2024; 11(5):1397-1405.

PMID: 39350386 PMC: 11436397. DOI: 10.14283/jpad.2024.135.


The inverse association between cancer history and incident cognitive impairment: Addressing attrition bias.

Shardell M, Rathbun A, Gruber-Baldini A, Ryan A, Guralnik J, Kapogiannis D Alzheimers Dement. 2024; 20(11):7902-7912.

PMID: 39324538 PMC: 11567823. DOI: 10.1002/alz.14268.


Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery.

Lu K, Zhou X Sci Signal. 2024; 17(841):eadi8743.

PMID: 38889227 PMC: 11409840. DOI: 10.1126/scisignal.adi8743.


Causal relationship between Alzheimer's disease and prostate cancer: a bidirectional Mendelian randomization analysis.

Li R, Peng L, Deng D, Li G, Wu S Front Endocrinol (Lausanne). 2024; 15:1354528.

PMID: 38544686 PMC: 10965771. DOI: 10.3389/fendo.2024.1354528.


Exploring the association between cancer and cognitive impairment in the Australian Imaging Biomarkers and Lifestyle (AIBL) study.

Ma L, Low Y, Zhuo Y, Chu C, Wang Y, Fowler C Sci Rep. 2024; 14(1):4364.

PMID: 38388558 PMC: 10884016. DOI: 10.1038/s41598-024-54875-3.